Open AccessChoosing optimal cerebroprotection strategy for polymorbid stroke patient
Author(s) -
О Д Остроумова,
I. A. Alyautdinova,
Т. М. Остроумова,
E. Yu. Ebzeeva,
Е. Е. Павлеева
Publication year - 2020
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2020-2-15-19
Subject(s) - citicoline , stroke (engine) , neuroprotection , cognition , ischemic stroke , medicine , cognitive impairment , physical medicine and rehabilitation , anesthesia , psychiatry , pharmacology , ischemia , mechanical engineering , engineering
The clinical example in this article shows the successful experience of using the neuroprotective agent citicoline (Noocyl) in a comorbid patient after an ischemic stroke with motor and cognitive impairment in combination with antihypertensive, hypolipidemic, and antiplatelet therapy. High efficiency and good tolerance of this drug, the ability to improve cognitive and motor processes are shown.